- Home
- LSEA vs EBS Comparison
LSEA vs EBS Comparison
Compare LSEA & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSEA
- EBS
- Stock Information
- Founded
- LSEA 2013
- EBS 1998
- Country
- LSEA United States
- EBS United States
- Employees
- LSEA N/A
- EBS N/A
- Industry
- LSEA Homebuilding
- EBS Biotechnology: Pharmaceutical Preparations
- Sector
- LSEA Consumer Discretionary
- EBS Health Care
- Exchange
- LSEA Nasdaq
- EBS Nasdaq
- Market Cap
- LSEA 447.4M
- EBS 459.6M
- IPO Year
- LSEA N/A
- EBS 2006
- Fundamental
- Price
- LSEA $10.85
- EBS $9.40
- Analyst Decision
- LSEA Buy
- EBS Strong Buy
- Analyst Count
- LSEA 4
- EBS 2
- Target Price
- LSEA $15.50
- EBS $14.00
- AVG Volume (30 Days)
- LSEA 192.1K
- EBS 1.6M
- Earning Date
- LSEA 11-04-2024
- EBS 11-06-2024
- Dividend Yield
- LSEA N/A
- EBS N/A
- EPS Growth
- LSEA N/A
- EBS N/A
- EPS
- LSEA 0.73
- EBS N/A
- Revenue
- LSEA $1,461,271,000.00
- EBS $1,125,500,000.00
- Revenue This Year
- LSEA $33.97
- EBS $7.98
- Revenue Next Year
- LSEA $1.97
- EBS $6.62
- P/E Ratio
- LSEA $14.45
- EBS N/A
- Revenue Growth
- LSEA 18.01
- EBS 2.05
- 52 Week Low
- LSEA $8.28
- EBS $1.42
- 52 Week High
- LSEA $14.91
- EBS $15.10
- Technical
- Relative Strength Index (RSI)
- LSEA 47.12
- EBS 50.73
- Support Level
- LSEA $10.35
- EBS $8.12
- Resistance Level
- LSEA $10.92
- EBS $12.68
- Average True Range (ATR)
- LSEA 0.56
- EBS 0.91
- MACD
- LSEA 0.01
- EBS -0.18
- Stochastic Oscillator
- LSEA 29.28
- EBS 33.67
About LSEA Landsea Homes Corporation
Landsea Homes Corp is a homebuilding company. It designs and builds homes and sustainable master-planned communities in some of the nation's desirable markets. The company's segments include Arizona, California, Florida, Metro New York, and Texas. It derives a majority of revenue from home sales in Florida.
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company operates across three different segments, namely Commercial, Products, and Services. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.